These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Adverse effects of proton pump inhibitors. Lodato F; Azzaroli F; Turco L; Mazzella N; Buonfiglioli F; Zoli M; Mazzella G Best Pract Res Clin Gastroenterol; 2010 Apr; 24(2):193-201. PubMed ID: 20227032 [TBL] [Abstract][Full Text] [Related]
45. Proton pump inhibitors, fracture risk and selection bias: three studies, same database, two answers. de Vries F; van Staa TP; Leufkens HG Osteoporos Int; 2011 May; 22(5):1641-2. PubMed ID: 20563562 [No Abstract] [Full Text] [Related]
46. Acid suppressants and hip fracture: duplicate publication bias? Bazelier M; de Boer A; de Vries F Bone; 2011 Oct; 49(4):920; author reply 921. PubMed ID: 21820528 [No Abstract] [Full Text] [Related]
47. Acid suppressants, fracture, and statistical adjustments for body mass index, smoking status, and calcium/vitamin D intake. de Vries F Am J Gastroenterol; 2011 Nov; 106(11):2051. PubMed ID: 22056590 [No Abstract] [Full Text] [Related]
48. Safety of long-term PPI use. Med Lett Drugs Ther; 2017 Aug; 59(1527):131-133. PubMed ID: 28787743 [No Abstract] [Full Text] [Related]
49. Proton pump inhibitors: too much of a good thing? Weekes LM Med J Aust; 2015 May; 202(9):464. PubMed ID: 25971558 [No Abstract] [Full Text] [Related]
50. Proton pump inhibitor therapy and osteoporosis. Yang YX Curr Drug Saf; 2008 Sep; 3(3):204-9. PubMed ID: 18691003 [TBL] [Abstract][Full Text] [Related]
51. The effect of proton pump-inhibiting drugs on mineral metabolism. Insogna KL Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S2-4. PubMed ID: 19262542 [TBL] [Abstract][Full Text] [Related]
52. Proton pump inhibitor side effects and drug interactions: much ado about nothing? Madanick RD Cleve Clin J Med; 2011 Jan; 78(1):39-49. PubMed ID: 21199906 [TBL] [Abstract][Full Text] [Related]
53. Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infection. Cat TB; Charash W; Hebert J; Marden BT; Corbett SM; Ahern J; Rebuck JA Ann Pharmacother; 2008 Feb; 42(2):185-91. PubMed ID: 18212256 [TBL] [Abstract][Full Text] [Related]
54. Proton Pump Inhibitors and Fractures During Growth. Sugiyama T JAMA Pediatr; 2021 Feb; 175(2):208-209. PubMed ID: 32986077 [No Abstract] [Full Text] [Related]
55. Proton Pump Inhibitors and Fractures During Growth-Reply. Wang YH; Pasternak B JAMA Pediatr; 2021 Feb; 175(2):209-210. PubMed ID: 32986123 [No Abstract] [Full Text] [Related]
56. Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study. Chiu HF; Huang YW; Chang CC; Yang CY Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1131-6. PubMed ID: 20872906 [TBL] [Abstract][Full Text] [Related]
57. Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis. Lai SW; Kuo YH; Liao KF Ann Rheum Dis; 2020 Dec; 79(12):e156. PubMed ID: 31300456 [No Abstract] [Full Text] [Related]
58. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577 [TBL] [Abstract][Full Text] [Related]